Kinder Morgan, Inc. (KMI)
Live price chart, market sentiment, and community perspectives for Kinder Morgan, Inc. (NYSE: KMI).
Live price chart, market sentiment, and community perspectives for Kinder Morgan, Inc. (NYSE: KMI).
On our macro desk, we are seeing a stark divide on KMI. Wall Street analysts are relatively constructive with 11 buys out of 23 ratings and an average target of $35.62, yet the retail crowd on platforms like X and Polymarket is flashing red or sitting completely on the sidelines. Elevated long-term Treasury yields are putting a wet blanket on income-oriented infrastructure plays, causing profit-taking despite stellar Q2 metrics.
Watching the 50-day moving average and recent price action, KMI's 3.1% slide reflects classic profit-taking and broader market pressure rather than any operational misstep. The company just delivered record Q2 net income of $867 million and raised its full-year guidance, backed by commodity price tailwinds in its enhanced oil recovery and natural gas segments. The fundamentals remain remarkably solid.
As a hedge fund portfolio manager, I find the sentiment spread fascinating. X runs roughly 60% bullish, while prediction markets like Polymarket show zero traction, and crowd sentiment averages a meager 16% bullishness over a 39-mention sample size. This lack of broad retail buzz or short-term catalysts keeps the stock rated as an Adanos Sell from a crowd momentum perspective, even if the underlying balance sheet is sound.
From a fundamental bio-analyst perspective transitioning into energy infrastructure, the real thesis for KMI isn't a simple commodity price upswing. It's about secular demand shifts. Their $9.6 billion project backlog is 92% natural gas, with over 60% tied directly to power generation and utility needs. That provides a durable, long-duration channel linked to electric reliability and LNG development.
In evaluating pipeline operators, investors often overlook the structural tailwinds from LNG and power generation demand. KMI's second-quarter adjusted EBITDA beat consensus at $2.20 billion versus PitchBook's $2.06 billion estimate, proving that volume growth in natural gas and terminals can successfully outpace legacy declines as projects successfully enter commercial service and draw down the backlog.
Explore plasma cleansing, somatic organ swaps, and BCI.